Literature DB >> 2404505

Improved strategies for secondary operations on infrainguinal arteries.

F J Veith1, S K Gupta, E Ascer, S P Rivers, K R Wengerter.   

Abstract

Secondary interventions play an important role in achieving the ultimate goal of limb salvage after primary infrainguinal interventions fail. By employing the described strategies and principles for secondary arterial reconstructions below the inguinal ligament, good results in terms of patency of the reoperated primary reconstruction or the secondary reconstruction can be obtained with significantly augmented limb salvage at a low cost in operative morbidity and mortality. These results mandate that vascular surgeons maintain an aggressive attitude toward the use of these secondary operations when a primary procedure fails to achieve or maintain its intended goal and a patient is faced with imminent limb loss because of distal ischemia.

Entities:  

Mesh:

Year:  1990        PMID: 2404505     DOI: 10.1007/BF02042697

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Analysis of endovascular graft treatment for aortoiliac occlusive disease: what is its role based on midterm results?

Authors:  R A Wain; F J Veith; M L Marin; T Ohki; W D Suggs; J Cynamon; J Goldsmith; L A Sanchez
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

2.  Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia.

Authors:  F J Veith; S K Gupta; K R Wengerter; J Goldsmith; S P Rivers; C W Bakal; A M Dietzek; J Cynamon; S Sprayregen; M L Gliedman
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

3.  Perigraft Seroma Presenting as Discharging Sinus and Spontaneous Exteriorization of Vascular Graft - A Rare Entity Following Vascular Repair with PTFE Graft.

Authors:  Annu Babu; Manish Kumar Pandey; Amit Gupta; Piyush Ranjan; Maneesh Singhal
Journal:  J Clin Diagn Res       Date:  2015-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.